No one can accuse Pfizer leadership of timidity. With the nation mired in a deep recession, the company Tuesday launched the second largest U.S.-dollar bond issue in history, a $13.5 billion offering to help fund its $68 billion acquisition of Wyeth. (It's exceeded only by Roche's recent $16 billion for its Genentech buy.) Report